Respiratory Syncytial Virus

2025-2026 RSV Prevention Program Update

Respiratory Syncytial virus (RSV) causes respiratory illness that affects the lungs and airways, and can be more serious for infants, children, and older adults. RSV typically circulates between late October and April, but can shift slightly from year to year. 

1. Older Adult RSV Prevention Program

Ontario’s publicly funded adult RSV prevention program has expanded for the 2025-2026 fall season!  

Ontario residents 75 years of age and older, along with those aged 60-74 who meet certain high-risk criteria, are eligible to receive a publicly funded dose of RSV vaccine this fall. If you have received a dose of RSV vaccine in the past, you do not need to receive another dose this season. Contact your healthcare provider to book an appointment. 

If you are aged 60 and older and do NOT qualify for the publicly funded RSV vaccine program, you can obtain the RSV vaccine from a pharmacy with a prescription from your healthcare provider. You will be required to pay for the cost of the vaccine, although some private insurers may cover all or part of the cost. 

For further information, visit: Older Adult RSV Prevention Program

2. Infant and high-risk children RSV update:

Beginning October 1, eligible newborns and infants can receive the monoclonal antibody, Beyfortus and pregnant individuals have the option to receive the RSV vaccine, Abrysvo.

To ensure protection through respiratory season, it is recommended that eligible children receive their dose of Beyfortus in the fall, as the immunization offers 6 months of protection. For more information and to book your appointment, speak to your healthcare provider.

For further information visit: Infant and High-Risk Children RSV Program